Clinical Trials Browser

NIH × Carcinoma, Hepatocellular × Fluorodeoxyglucose F18 × Clear all

Urinary Bladder Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Ovarian Neoplasms, Paraganglioma, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

NCT05009979 2025-08-28

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

Phase 2 Terminated

8 enrolled 14 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00019604 2017-02-03

Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Phase 2 Terminated

44 enrolled 7 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

Clinical Trials

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer